
Sign up to save your podcasts
Or


Part 1 has landed!
Join in on their conversation on the Cell and Gene Therapy industry.
Some topics that Darwin and Rajiv discuss in this episode are:
- The current status of cell and gene therapy approvals,
- CMC challenges
- AAV-based gene therapy
Stay tuned to part 2 of their conversation. Remember to subscribe to the podcast to get the latest releases
Rajiv Gangurde LinkedIn profile: https://www.linkedin.com/in/rajiv-gangurde-ph-d-5b8ab5a/
Part 3 is Here! Join Darwin and Aaron Snyder, VP of Quality at Allotex, as they wrap up with a powerful discussion on career growth, the critical role of career ladders, and how they drive higher retention, stability, and reduced risk in organizations.
Aaron Snyder LinkedIn: https://www.linkedin.com/in/aaron-snyder-mscgmp/
Join us as we continue our discussion with Aaron Snyder, VP of Quality at Allotex.
In this second installment, Darwin and Aaron define a stellar "Quality" candidate, highlight the significance of crossover skills, and the keys to assembling high-impact teams.
Listen now for insights into leadership and team development. Also stay tuned next week for Part 3, where we'll explore even more facets of industry-leading strategies.
Aaron Snyder LinkedIn: https://www.linkedin.com/in/aaron-snyder-mscgmp/
New Episode! Dive into Part 1 of our engaging three-part series on the SSI Executive Conversations podcast, featuring Aaron Snyder, VP of Quality at Allotex. In this episode, Aaron shares his inspiring career journey and gives us a behind-the-scenes look at what makes Allotex a standout company and why he joined. Stay tuned for Parts 2 and 3 in the coming weeks, where we'll explore different facets of leadership and innovation. Don't miss this chance to gain insights from one of the industry's most forward-thinking leaders.
Aaron Snyder LinkedIn: https://www.linkedin.com/in/aaron-snyder-mscgmp/
#SSIExecutiveConversations #CareerJourney #Allotex #Leadership #Innovation
Now Live: Part 2 of our captivating series on SSI Executive Conversations, featuring Janet Johnson, VP of Global Regulatory at Terumo BCT! Janet offers her expert take on nurturing talent within an organization, emphasizing the critical role of a growth mindset in driving personal and professional development. The conversation also navigates the advantages and disadvantages of remote versus hybrid work, providing insights into how Terumo BCT is adapting to these evolving workplace dynamics.
Janet Johnson LinkedIn: https://www.linkedin.com/in/janet-johnson-leader-mentor/
Launching Our Next Series: Join us for Part 1 of an enlightening two-part series on SSI Executive Conversations Podcast, where Darwin hosts Janet Johnson, VP of Global Regulatory at Terumo BCT. In this episode, Janet shares the lessons learned throughout her career, highlighting the importance of balancing risk with innovation and how to cultivate a team that thrives on this principle. And make sure to subscribe to the SSI Executive Conversations Podcast so you stay up to date with all the latest news and get early access to upcoming episodes!
Janet Johnson LinkedIn: https://www.linkedin.com/in/janet-johnson-leader-mentor/
Darwin and Dr. Street delve into the crucial role of cultivating a strong business culture, laying the foundation for lasting success and innovation.
Discover the strategies behind building an environment that not only attracts but also retains the right talent, aligned with the core values and vision of Inovus Surgical. Dr. Street shares his insights on identifying and hiring individuals who contribute to and thrive within this culture, ensuring the company's mission is embodied at every level.
Dr Elliot Street is the co-founder and CEO of Inovus Medical, a multi-award-winning designer and manufacturer of surgical training technology.
This episode is part 1 of 2.
In this episode, they explore the fascinating origins of Inovus and the groundbreaking ways in which the company is revolutionizing Surgical Training technology.
Elliot Street LinkedIn https://www.linkedin.com/in/elliot-street-77900771/
On this next SSI Executive Conversation episode, Darwin and Robert explore the nuances of regulatory pathways in the medical industry. They dissect critical insights, including the need to avoid a transactional approach in regulatory processes and the importance of strategic planning to mitigate risks. The podcast sheds light on the high rate of FDA rejections for 510K applications and emphasizes the significance of emotional intelligence in regulatory professionals for successful submissions. Furthermore, considerations between consulting and full-time positions within the RA career path.
You can contact Robert at www.CadenceRegulatory.com
#RegulatoryInsights #MedicalIndustry #StrategicPlanning
Robert has worked in Med Device Regulatory Affairs for over 30 years, including orthopedic implants and cardiovascular devices. He specializes in Regulatory strategy, writing successful regulatory submissions, and negotiating with the FDA and EU Notified Bodies. He works as a consultant for small to midcap companies and is the President at Cadence Regulatory, LLC.
In this episode, Darwin and Robert discuss regulatory pathways, emphasizing key considerations for executives. Learn about strategic dos and don'ts to ensure a smooth journey through governing body's processes, preventing resource wastage and opportunity costs post-submission. Robert, with vast experience in successful submissions, sheds light on the crucial role regulatory plays in the C-Suite, influencing strategic decisions for growth and risk mitigation.
To contact Robert please visit www.CadenceRegulatory.com
#MarketAccess #FDAsubmissions #riskmitigation
From the publisher's feed
The SSI Team meets with the executives from across the Medtech, pharma, and life science space and brings fascinating insights to our following.